What GLP-1 Medications Actually Cost in Tampa Bay Without Insurance
For a Tampa Bay patient paying without insurance, the current published self-pay cost of a branded GLP-1 or related weight management medication generally starts between $199 and $449 per month. However, introductory prices, starter doses, refill deadlines, professional fees, and laboratory costs can make the real expense significantly different from the number shown in an advertisement.
As of August 2026, Zepbound’s published self-pay program ranges from $299 to $449 per month, while standard Wegovy injection generally costs $349 per month after its introductory offer. Wegovy HD costs $399 per month. Diabetes medications such as Ozempic and Mounjaro have separate pricing and should not be treated as interchangeable, lower-cost versions of obesity medications.
The important question is not simply, “How much is the shot?” It is, “What will the complete, medically supervised treatment cost at the dose I am likely to use?”
GLP-1 Cost Without Insurance in 2026
The following figures are current manufacturer-published self-pay prices. They may change, and eligibility requirements, taxes, pharmacy fees, and program terms may apply.
| Medication | FDA-approved use relevant to this discussion | Current published self-pay price |
| Zepbound 2.5 mg | Starting dose for chronic weight management | $299 per 28 days |
| Zepbound 5 mg | Weight management maintenance dose | $399 per 28 days |
| Zepbound 7.5 mg through 15 mg | Higher weight management doses | $449 per 28 days through the Self Pay Journey Program when refill requirements are met |
| Wegovy pen 0.25 mg or 0.5 mg | Introductory weight management doses | $199 per month for the first two eligible fills for new self-pay patients |
| Wegovy pen 0.25 mg through 2.4 mg | Standard injection doses after introductory pricing | $349 per month |
| Wegovy HD 7.2 mg | Higher-dose weight management injection | $399 per month |
| Wegovy pill 1.5 mg and 4 mg | Early oral titration doses | $149 per month under the current limited offer |
| Ozempic pen | Type 2 diabetes, not specifically approved as a weight loss medication | $349 per month for doses through 1 mg and $499 for 2 mg after eligible introductory pricing |
| Mounjaro pen | Type 2 diabetes, not specifically approved as a weight loss medication | Starting at $499 per month through LillyDirect |
These are national manufacturer programs, so a patient in Lutz, Wesley Chapel, New Tampa, Land O’ Lakes, Clearwater or St. Petersburg may see the same published drug price. What changes locally is the cost of the clinical program, consultations, laboratory testing, body composition monitoring and follow-up care.
What Zepbound Actually Costs Without Insurance
Zepbound currently has one of the clearest self-pay structures for adults with a valid prescription for an FDA-approved use.
The 2.5 mg starting dose is $299 for a 28-day supply. The 5 mg dose is $399. Doses from 7.5 mg through 15 mg can cost $449 through the Zepbound Self Pay Journey Program.
There is an important condition: patients using the $449 higher-dose offer must generally complete the next refill purchase within 45 days of receiving the previous supply. Missing that window can cause the regular price to apply.
Lilly currently lists the regular self-pay price as $499 for 7.5 mg and $699 for the 10 mg, 12.5 mg and 15 mg doses when the Journey Program purchase offer does not apply.
That refill requirement matters. A patient who delays treatment because of travel, illness, a procedure, or side effects should not assume the same price will still apply automatically.
Zepbound is available in single-dose vials and a single-patient-use KwikPen. Vials may require a separate needle and syringe purchase, while the KwikPen contains four weekly doses in one device.
What Wegovy Actually Costs Without Insurance
Wegovy now has three distinct formats: the standard weekly injection, the higher-dose Wegovy HD injection, and the once-daily Wegovy pill.
For new eligible self-pay patients, Novo Nordisk currently advertises the 0.25 mg and 0.5 mg injection doses for $199 per month for the first two fills through December 31, 2026. After that introductory period, Wegovy injection doses from 0.25 mg through 2.4 mg are published at $349 per month. Wegovy HD 7.2 mg is $399 per month.
The Wegovy pill is advertised as starting at $149 per month for the 1.5 mg dose. The manufacturer’s current terms also list the 4 mg dose at $149 through August 31, 2026, after which the 4 mg price is scheduled to increase to $199.
The phrase “starting at $149” requires attention. The 1.5 mg and 4 mg tablets are early titration doses. The usual maintenance dose is 25 mg daily, so a patient should verify the cost of the prescribed maintenance dose rather than assuming the starter price will continue throughout treatment.
The pill also requires a strict dosing routine. It must be taken in the morning on an empty stomach with no more than four ounces of water, followed by a 30-minute wait before food, beverages, or other oral medications. For some patients, a weekly injection will be easier to use consistently than a daily pill.
Why Ozempic and Mounjaro Prices Create Confusion
Ozempic and Mounjaro are FDA-approved for type 2 diabetes. Wegovy and Zepbound are the corresponding brands approved for chronic weight management.
Although the medications share active ingredients with their obesity-treatment counterparts, they are not automatically interchangeable from a prescribing, dosing, insurance or regulatory standpoint.
Ozempic’s current self-pay program lists an introductory price of $199 for the first two months of the 0.25 mg or 0.5 mg pen for eligible new patients. Subsequent pricing is $349 per month for 0.25 mg, 0.5 mg, or 1 mg and $499 for the 2 mg dose.
Mounjaro is currently available through LillyDirect starting at $499 per month. Lilly also reports a list price of $1,112.16 for a 28-day supply when a patient does not have applicable coverage or savings.
A patient without type 2 diabetes should not select Ozempic or Mounjaro simply because a temporary price appears lower. The prescription must be clinically appropriate, and the patient should understand which indication, product, dose, and monitoring plan are being used.
Does “$299 Per Month” Include the Medical Program?
Usually not.
A manufacturer’s self-pay price generally covers the medication. It may not include:
The initial medical evaluation, follow-up appointments, baseline or repeat laboratory testing, body composition analysis, nutrition guidance, injection supplies, shipping charges, treatment for side effects or management of the patient’s other medical conditions.
Some Tampa Bay weight loss clinics advertise one bundled monthly price. Other practices separate the medication, clinical membership, and laboratory costs. Neither model is automatically better, but the patient should know exactly what is included.
A program advertised at $350 may become more expensive after consultation and laboratory fees are added. Conversely, a higher monthly program may include ongoing primary care access, laboratory monitoring, and clinical support that would otherwise be billed separately.
The Cheapest Advertised Price May Be a Starter Dose
GLP-1 advertisements frequently feature the lowest available dose because it produces the lowest headline price.
Zepbound 2.5 mg is a treatment-initiation dose, not a maintenance dose. Wegovy pill 1.5 mg is also a starting dose. A patient who responds appropriately may advance to a higher and more expensive dose.
This does not mean every patient needs the maximum dose. Some patients achieve adequate appetite control and metabolic improvement at a lower maintenance dose. Others require gradual escalation.
The relevant financial question is not, “What does the first month cost?” It is, “What is the likely cost at month six?”
What About Compounded Semaglutide or Tirzepatide?
Compounded products are often advertised at a lower monthly price, but they are not FDA-approved versions of Wegovy, Ozempic, Zepbound or Mounjaro.
The FDA states that a compounded drug should be used only when a patient’s medical need cannot be met by an available FDA-approved drug. Compounded medications do not undergo the same premarket review for safety, effectiveness or manufacturing quality.
This does not mean every legally compounded medication is fraudulent or inappropriate. It means the source, indication and formulation matter.
In 2026, the FDA intensified enforcement against companies mass-marketing unapproved GLP-1 products as equivalents or generic versions of approved drugs. The agency has also warned about dosing errors, inconsistent concentrations, improper refrigeration, fraudulent labeling and the use of semaglutide salt forms that differ from the active ingredient in FDA-approved products.
As of May 31, 2026, the FDA had received 990 adverse-event reports associated with compounded semaglutide and more than 730 associated with compounded tirzepatide. Reporting is incomplete because many state-licensed compounding pharmacies are not required to submit adverse events to the FDA.
When discussing a compounded product, patients should be told:
- The exact medication and concentration
- The dose in milligrams, not only “units”
- The name and license status of the dispensing pharmacy
- Whether the product contains semaglutide base or an unapproved salt form
- How it must be stored and shipped
- Whether syringes and supplies are included
- What happens if the concentration changes
- Who is available if an adverse reaction occurs
The word “compounded” should never be used as though it identifies one standardized product.
The Real Cost of Poorly Supervised GLP-1 Treatment
A low medication price does not create value when the patient is receiving inadequate monitoring.
GLP-1 treatment can change appetite so substantially that patients unintentionally consume too little protein, fluid, fiber or total nutrition. Rapid weight reduction may include loss of lean tissue as well as fat. Constipation, vomiting and diarrhea can lead to dehydration or kidney stress. Gallbladder problems, pancreatitis symptoms, changes in glucose-lowering medication requirements and worsening gastrointestinal symptoms may require clinical intervention.
The treatment plan must also account for the patient’s blood pressure medications, diabetes medications, oral contraceptives, upcoming procedures and other health conditions.
This is where direct primary care and functional medicine can produce a different level of value. The provider is not managing one injection in isolation. The medication is integrated into the patient’s complete medical history and long-term health plan.
How South Beach Wellness Center Approaches GLP-1 Cost
Maribel Dixon, MSN, APRN, FNP-C, combines medical weight management with direct primary care, hormone evaluation and chronic disease management. Her role is not limited to determining whether someone qualifies for a prescription.
A comprehensive evaluation may identify factors such as uncontrolled blood pressure, prediabetes, abnormal cholesterol, metabolic liver disease, sleep apnea, thyroid dysfunction, menopausal symptoms, low testosterone, medication-related weight gain or digestive problems that affect the treatment decision.
This approach also helps prevent patients from paying indefinitely for a medication without knowing whether it is improving the health outcomes that matter.
Patients at South Beach Wellness Center’s Lutz office, near Wesley Chapel, Land O’ Lakes and New Tampa, can discuss branded medication access, dosing, monitoring and the other costs associated with a medically supervised program. South Beach Wellness Center also provides direct primary care, allowing weight management to be coordinated with the patient’s ongoing preventive and chronic care needs.
Questions to Ask Before Paying for a Tampa Bay GLP-1 Program
Before enrolling, ask for the exact name of the medication, the dose included in the quoted price and whether the price increases as the dose increases.
Ask whether the medication is FDA approved or compounded. When it is compounded, request the pharmacy’s name and the exact concentration.
Ask which consultations, follow-up visits, laboratory tests, body composition measurements and supplies are included. Determine whether there is an enrollment fee, cancellation policy, shipping fee or restart fee after a treatment interruption.
Finally, ask who will manage nausea, constipation, vomiting, dehydration, medication interactions or abnormal laboratory results. The answer reveals whether the program is selling access to medication or providing medical care.
Frequently Asked Questions
How much is Zepbound without insurance in Tampa Bay?
Current manufacturer self-pay pricing starts at $299 for the 2.5 mg dose, $399 for 5 mg and $449 for doses from 7.5 mg through 15 mg when the higher-dose refill program requirements are met.
How much is Wegovy without insurance?
New eligible self-pay patients may pay $199 for each of the first two fills of the 0.25 mg or 0.5 mg pen. Standard Wegovy pen doses are then published at $349 per month, and Wegovy HD is $399 per month.
Is the Wegovy pill really $149?
The manufacturer currently advertises $149 pricing for the 1.5 mg and, for a limited period, the 4 mg tablet. These are titration doses. Patients should verify the price of the maintenance dose prescribed to them.
Is compounded semaglutide cheaper?
It may have a lower advertised price, but the price cannot be evaluated without knowing the pharmacy, concentration, dose, included medical care and whether there is a patient-specific need that cannot be met by an approved product.
Are laboratory tests included in the medication price?
Manufacturer self-pay prices generally cover the medication, not a clinic’s consultation, laboratory or monitoring fees. Each program should provide a written explanation of what is included.
Medical Disclaimer
Medication prices and manufacturer programs can change without notice. Prices discussed in this article were current as of August 3, 2026 and may be subject to eligibility requirements, taxes, pharmacy charges and program terms. This information does not constitute a prescription or guarantee of pricing. GLP-1 and GIP/GLP-1 medications require an individualized medical evaluation and ongoing clinical monitoring.
